Dr. Sumanth N Pagadala, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 North Ave, Columbus, GA 31904 Phone: 706-327-5547 Fax: 706-323-6821 |
Richard Harding Wilson, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 North Ave, Columbus, GA 31904 Phone: 706-327-5547 Fax: 706-323-6821 |
Mohan Kumar Sadana, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 616 19th St Fl 4, Columbus, GA 31901 Phone: 706-494-4075 |
Shenita White, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2430 Brookstone Centre Pkwy, Columbus, GA 31904 Phone: 706-494-7700 |
Dr. Vincent Antonio Naman, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1921 Whittlesey Rd, Suite 200, Columbus, GA 31904 Phone: 706-494-7700 Fax: 706-494-8800 |
News Archive
The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.
Politico Pro reports that Centers for Medicare & Medicaid Services official Cindy Mann outlined Monday how states could choose to expand their coverage under the health law and then later drop it if they choose. This is the first time states will be allowed to drop such new coverage. Meanwhile, Modern Healthcare reports on how employers might be impacted if states opt not to expand their Medicaid programs.
The space within reach of our hands - where actions such as grasping and touching occur - is known as the "action space." Research has shown that visual information in this area is organized in hand-centered coordinates - in other words, the representation of objects in the human brain depends on their physical location with respect to the hand.
XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, TX were published today in Lancet Oncology. The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix™, XBiotech's novel, non-cytotoxic, anti-tumor therapy.
› Verified 1 days ago